In addition, although IL-17R responses are induced after infection, the control of fungal proliferation is not reliant on the IL-17 signaling axis during VVC, and patients receiving IL-17 pathway-targeted mAbs have not been reported to be at a significant risk for VVC [163,230]. The gene discussed is IL17RA; the disease is infection.